PRESS RELEASE published on 03/21/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
BRIEF published on 02/28/2025 at 07:35, 1 year 6 months ago ABIONYX renforce son engagement contre la Déficience LCAT Autorisation De Mise Sur Le Marché Maladie Rare Déficience LCAT Biomédicament Maladie De Norum
BRIEF published on 02/28/2025 at 07:35, 1 year 6 months ago ABIONYX strengthens its commitment against LCAT Deficiency Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
PRESS RELEASE published on 02/28/2025 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE published on 02/28/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF published on 02/27/2025 at 19:25, 1 year 6 months ago ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024 2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
BRIEF published on 02/27/2025 at 19:25, 1 year 6 months ago ABIONYX Pharma annonce un chiffre d'affaires et une situation de trésorerie stables pour 2024 Résultats Financiers 2024 ABIONYX Pharma Thérapies Innovantes Accès Compassionnel Industrie Des CRO
PRESS RELEASE published on 02/27/2025 at 19:20, 1 year 6 months ago Inside Information / Information on annual revenues ABIONYX Pharma reports €4.6m revenue and €3.2m cash at the end of Q4 2024. Details on business activities and financial performance included Revenue Cash Position Financial Update Biopharma ABIONYX Pharma
PRESS RELEASE published on 02/27/2025 at 19:20, 1 year 6 months ago Informations privilégiées / Information sur chiffre d’affaires annuel ABIONYX Pharma annonce un chiffre d'affaires consolidé de 4,6M€ et une trésorerie de 3,2M€ au 31 décembre 2024 Chiffre D'affaires Trésorerie Biopharma ABIONYX Pharma Thérapies Innovantes
BRIEF published on 02/20/2025 at 07:35, 1 year 7 months ago ABIONYX Pharma reçoit un soutien de 8,7 millions d'euros pour son projet sur le sepsis France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
Published on 09/25/2026 at 15:00, 1 hour ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 2 hours ago Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 3 hours ago American Hotel Income Properties REIT LP Announces Corporate Update
Published on 09/25/2026 at 13:00, 3 hours ago UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach
Published on 09/25/2026 at 15:50, 10 minutes ago Zentra Group plc: One Victoria – Replacement Building Contract Signed
Published on 09/25/2026 at 15:37, 23 minutes ago EQS-Adhoc: RAG-Stiftung: RAG-Stiftung regarding a potential takeover of Evonik by BASF
Published on 09/25/2026 at 15:30, 30 minutes ago Les dirigeants africains appellent à renforcer le financement national et l'action multisectorielle pour accélérer l'élimination du paludisme
Published on 09/25/2026 at 15:30, 30 minutes ago African leaders call for stronger domestic financing and multisectoral action to accelerate malaria elimination
Published on 09/25/2026 at 15:12, 48 minutes ago EQS-Adhoc: Evonik Industries AG confirms receipt of a non-binding approach from BASF SE regarding a potential takeover offer
Published on 09/25/2026 at 07:00, 8 hours 59 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 21 hours 28 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 22 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 22 hours ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
